Stay updated with breaking news from Ch0012005267. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
By Adriano Marchese Lantheus Holdings is being sued by Swiss multinational pharmaceutical Novartis for patent infringement on a generic drug to treat. ....
By Adria Calatayud Novartis's investigational drug iptacopan achieved its primary goal in a late-stage clinical trial for treatment of kidney disease C3. ....
By Helena Smolak Shares of Germany's Merck KGaA plunged after its experimental drug evobrutinib failed in two late-stage trials of patients with relapsing. ....
By Zaeem Shoaib The U.S. Food and Drug Administration is investigating certain CAR T cancer therapies based on reports that they might cause a type of white. ....
By Chris Wack Legend Biotech said its Legend Biotech Ireland subsidiary has entered into an exclusive, global license agreement for LB2102 with Novartis. ....